Novel 3D Model Provides Early Insights on Breast Cancer Spread
News
Mesenchymal stem cells — cells that can give rise to many cell types and travel to tumor sites — can reduce the capacity of breast cancer cells to spread to ... Read more
FDA Approves Nerlynx-Capecitabine Combo for HER2-positive Metastatic Breast Cancer
News
Nerlynx (neratinib) is now approved in the U.S. for use, in combination with capecitabine, to treat HER2-positive breast cancer patients who have received two or more HER2-targeted therapies for their metastatic ... Read more
New Formulation of Roche’s Perjeta-Herceptin Combo for HER2-Positive Breast Cancer Up for Possible FDA Approval
News
The U.S. Food and Drug Administration (FDA) will review Roche’s application seeking regulatory approval for a new formulation — given as a subcutaneous, or under-the-skin injection — of the fixed-dose ... Read more
Magseed Approval Extended in Europe for Soft Tissues, Long-Term Implantation
News
Magseed, a small magnetic marker by Endomag designed to accurately mark the site of cancer cells before surgery, is now approved in Europe for use in any soft tissue and ... Read more
Adding Keytruda to Chemo Slows Worsening in Advanced TNBC with PD-L1 Markers, Trial Finds
News
First-line treatment with Keytruda (pembrolizumab) and chemotherapy prolongs the time without disease worsening in people with advanced triple-negative breast cancer (TNBC) whose tumors are positive for the marker PD-L1, an interim analysis ... Read more
Tucatinib Granted FDA Priority Review for Advanced HER2-positive Breast Cancer
News
The U.S. Food and Drug Administration (FDA) has granted priority review to Seattle Genetics’ application seeking approval of its investigational therapy tucatinib, in combination with trastuzumab and Xeloda (capecitabine), for treating people with locally advanced inoperable or metastatic HER2-positive breast cancer. This ... Read more
Tutu Project’s Pilot Program Helps Breast Cancer Patients Directly With Daily Expenses
News
The Tutu Project has awarded its first direct grants to patients and families battling breast cancer, as part of a new pilot program to help patients with their daily expenses. ... Read more
AutoNation Donates $720K to Breast Cancer Research Foundation
News
As part of its Drive Pink initiative, AutoNation has donated $720,000 to the Breast Cancer Research Foundation (BCRF) to support research aimed at disease prevention, diagnosis and treatment. The funds ... Read more
Study of Treatment Aiming to Prevent Advanced Breast Cancer’s Spread to Bone Doses 1st Patient
News
GlycoMimetics announced that the first patient with advanced breast cancer has been dosed in a Phase 1b clinical trial investigating the ability of its small molecule inhibitor, GMI-1359, to stop breast ... Read more
Keytruda-Mektovi Combo Deemed Safe in Early Triple Negative Breast Cancer Trial
News
A combination of the immune checkpoint inhibitor Keytruda (pembrolizumab) and the melanoma therapy Mektovi (binimetinib) is safe and well-tolerated by people with advanced triple negative breast cancer, preliminary findings from ... Read more
Researcher Awarded $462K NIH Grant to Study Effects of Endocrine Disruptors on Breast Cancer Risk in Young Women
News
Research efforts to understand the effects of endocrine-disrupting chemicals (EDCs) on breast cancer risk in young women have been given a boost with a $462,000 grant from the National Institutes ... Read more
Susan G. Komen Tissue Bank Teams with LifeOmic to Advance Breast Cancer Research
News
A partnership between the Susan G. Komen Tissue Bank and LifeOmic, a software company, aims to help researchers globally gain insights into how breast cancer develops, and ways of better treating ... Read more